Index. B Bacillary angiomatosis versus Kaposi s sarcoma, 515 with HIV/AIDS, Bacterial folliculitis, versus pruritic papular eruption, 455
|
|
- Arron Singleton
- 5 years ago
- Views:
Transcription
1 Dermatol Clin 24 (2006) Index Note: Page numbers of article titles are in boldface type. A Actinic dermatitis, with HIV/AIDS, 446 Acute retroviral syndrome, acquisition of, 432 clinical features of, diagnosis of, 434 differential diagnosis of, 434 early identification of, 432 gastrointestinal complications of, 432 genitourinary complications of, 432 management of, highly active retroviral therapy in, 435 mucosal ulcers in, 432 neurologic complications of, 432 pathogenesis of, psychological impact of, pulmonary complications of, 432 transmission of, 433 Acyclovir, for varicella zoster virus, 477 Africa, HIV/AIDS epidemiology in. See HIV/ AIDS, global epidemiology of. AIDS. See HIV/AIDS. Alitretinoin gel, for Kaposi s sarcoma, 517 Anogenital lesions, in Kaposi s sarcoma, 513 Antimonial agents, for leishmaniasis, 487 Antiretroviral therapy, adjunctive, 542 adverse reactions to, 542 and hyperlipidemia, 543 and hypersensitivity syndrome, 542 and insulin resistance, 543 and lactic acidosis, and lipodystrophy, choice of regimen for, fusion inhibitors, 540 nonnucleoside reverse transcriptase inhibitors, 540 nucleoside reverse transcriptase inhibitors, protease inhibitors, 540 classes of, 538 combination therapy in, 542 dosing schedules and restrictions in, effects of, on Kaposi s sarcoma, 510, 515, 516 goals of, 544 highly active. See Highly active antiretroviral therapy. initiation of, metabolic complications of, 542 principles of, resistance testing in, resistance to, Antituberculosis drugs, adverse reactions to, Aqueous crystalline penicillin G, for neurosyphilis, 504 Argentina, HIV/AIDS epidemiology in, 416 Arthropod bites, versus pruritic papular eruption, 455 Arthropod hypersensitivity, and pruritic papular eruption, Asia, HIV/AIDS epidemiology in, Atopic dermatitis, with HIV/AIDS, 442 Australia, HIV/AIDS epidemiology in, 417 Azidothymidine, for HIV/AIDS, dermatologist epidemic watcher s perspective on, 409 Azithromycin, for syphilis, B Bacillary angiomatosis versus Kaposi s sarcoma, 515 with HIV/AIDS, Bacterial folliculitis, versus pruritic papular eruption, /06/$ - see front matter Ó 2006 Elsevier Inc. All rights reserved. doi: /s (06) derm.theclinics.com
2 572 INDEX Bacterial infections, with HIV/AIDS. See Cutaneous infections. Bahamas, HIV/AIDS epidemiology in, 415 Baltic states, HIV/AIDS epidemiology in, 415 Bartonella infections, with HIV/AIDS, Basal cell carcinoma. See Skin cancer. Benzathine penicillin G, for syphilis, 503, 504 Biopsy, skin, for acute retroviral syndrome, 434 Botryomycosis, with HIV/AIDS, 474 Brazil, HIV/AIDS epidemiology in, 416 Bullous drug reactions, in HIV infection, 462 Buruli ulcers, with HIV/AIDS, 485 C Candidiasis, with HIV/AIDS, Cardiovascular syphilis, with HIV infection, , 504 Caribbean, HIV/AIDS epidemiology in, CD4 lymphocyte count, and skin cancer, 522, 523 Ceftriaxione, for syphilis, 503 Central Africa, HIV/AIDS epidemiology in, Central Asia, HIV/AIDS epidemiology in, Central Europe, HIV/AIDS epidemiology in, Cerebrospinal fluid studies for neurosyphilis, 502 for syphilis, 504 Cervical cancer, with HIV/AIDS, Cervical intraepithelial neoplasia, with HIV/ AIDS, Chemotherapy, for Kaposi s sarcoma, 516, 517 China, HIV/AIDS epidemiology in, Coccidioidomycosis, with HIV/AIDS, Cryptococcosis syndrome and, 554, with HIV/AIDS, Cuba, HIV/AIDS epidemiology in, Cutaneous infections, with HIV/AIDS, bacterial, bacillary angiomatosis, Staphylococcus aureus, fungal, candidiasis, coccidioidomycosis, cryptococcosis, dermatophytosis, histoplasmosis, mycobacterial, 485 Penicillium marneffei, 483 Pneumocystis jiroveci, 483 parasitic, leishmaniasis, scabies, viral, cytomegalovirus, 478 Epstein-Barr virus, 478 herpes simplex virus, human papillomavirus, molluscum contagiosum virus, varicella zoster virus, Cytomegalovirus, with HIV/AIDS, 478 D Demodex folliculorum infestations, versus pruritic papular eruption, 453, 455 Dermatitis, with HIV/AIDS, , 446 Dermatomal zoster, with HIV/AIDS, Dermatophytosis, with HIV/AIDS, Dermatoses, inflammatory noninfectious. See Inflammatory noninfectious dermatoses. Dominican Republic, HIV/AIDS epidemiology in, 415 Doxorubicin, for Kaposi s sarcoma, 516, 517 Doxycycline, for syphilis, 503 Drug hypersensitivity syndrome antiretroviral therapy and, 542 in HIV infection, , 466 E East Africa, HIV/AIDS epidemiology in, 425 Eastern Europe, HIV/AIDS epidemiology in, Eczema, with HIV/AIDS, Enfuvirtide, for HIV infection, mechanism of action of, 540
3 Enzyme-linked immunosorbent assays, for acute retroviral syndrome, 434 Eosinophilic folliculitis, with HIV/AIDS. See Inflammatory noninfectious dermatoses. Epstein-Barr virus, with HIV/AIDS, 478 Ethiopia, HIV/AIDS epidemiology in, 425 Europe, HIV/AIDS epidemiology in, F Fat-redistribution syndrome, antiretroviral therapy and, Fluconazole, resistance to, in HIV/AIDS, 484 Fluorescent treponemal antibody absorption test, for syphilis, Folliculitis eosinophilic, with HIV/AIDS. See Inflammatory noninfectious dermatoses. versus pruritic papular eruption, 455 Fungal infections, with HIV/AIDS. See Cutaneous infections. Fusion inhibitors, mechanism of action of, 540 G Gastrointestinal complications, of acute retroviral syndrome, 432 Genital ulcers, with HIV/AIDS, 475 Genitourinary complications, of acute retroviral syndrome, 432 Genotypic resistance assays, in drug resistance testing, 544 Granulomatous foreign-body reactions, immune reconstitution inflammatory syndrome and, 555, Gummatous syphilis, with HIV infection, 500, 504 H Haiti, HIV/AIDS epidemiology in, 415 Herpes simplex virus infections syndrome and, 551, 552, with HIV/AIDS, Herpes zoster syndrome and, 552, with HIV/AIDS, in children, 534 INDEX 573 Highly active antiretroviral therapy and syndrome. See Immune reconstitution inflammatory syndrome. dermatologist epidemic watcher s perspective on, effects of on cervical intraepithelial neoplasia, 479 on cryptococcosis, on leishmaniasis, 487 on skin cancer, 523, 525 on varicella zoster virus, 477 for acute retroviral syndrome, 435 in children, Histoplasmosis syndrome and, 554, with HIV/AIDS, HIV/AIDS adverse drug reactions in, , 542 bullous reactions, 462 causality in, classification of, definition of, 459 diagnosis of, 461 dosage schedules and, 469 drug hypersensitivity syndrome, , 466, 542 drug provocation tests for, epidemiology of, immune stimulation and, 470 in tuberculosis patients, major histocompatibility complex and, 470 morbilliform exanthematous reactions, pathogenesis of, 469 Stevens-Johnson syndrome, , T-cell activation and, 470 to antituberculosis drugs, 468 to trimethoprim-sulfamethoxazole, toxic epidermal necrolysis, , and acute retroviral syndrome. See Acute retroviral syndrome. and skin cancer. See Skin cancer. cutaneous infections with. See Cutaneous infections. dermatologist epidemic watcher s perspective on, beginning of pandemic, 407 pandemic in retrospect,
4 574 INDEX HIV/AIDS (coninued) agent, 409 birth, 408 blood risk, 409 gender spread, 409 geographical spread, global disease and response, 410 lost generation and orphans, 409 origins, 408 prevention, 410 stigma, 409 treatment, prepandemic, resources, 411 skin disease as marker, 408 spin-off benefits, 410 global epidemiology of, Asia, Caribbean, Eastern Europe and Central Asia, Latin America, 416 Middle East and North Africa, 417 North America and Western and Central Europe, Oceania, 417 prevention strategies in, primary, 418 secondary, 418 tertiary, 418 sub-saharan Africa, 413, , cost-effective interventions in, cutaneous diseases in, East Africa, 425 expanding access to treatment, 426 factors contributing to, in women, 426 inadequate health care and, 421 mortality rates from, 421 prevention strategies in, 426 regional trends in, Southern Africa, West and Central Africa, in children, epidemiology of, highly active antiretroviral therapy for, syndrome in, immune status in, skin disease as indicator of, in sub-saharan Africa, incidence of, 532 vertical transmission of, 532 inflammatory noninfectious dermatoses with. See Inflammatory noninfectious dermatoses. Kaposi s sarcoma with. See Kaposi s sarcoma. pruritic papular eruption with. See Pruritic papular eruption. syphilis with. See Syphilis. Human herpesvirus 8, and Kaposi s sarcoma, , 552, Human papillomavirus, with HIV/AIDS, Hydroxyurea, with antiretroviral therapy, 542 Hyperlipidemia, antiretroviral therapy and, 543 I Imiquimod, for human papillomavirus, 479 Immune dysregulation, and pruritic papular eruption, 450 Immune reconstitution inflammatory syndrome, and cryptococcosis, 554, and eosinophilic folliculitis, 554, and granulomatous foreign-body reactions, 555, and herpes simplex virus infections, 551, 552, and herpes zoster virus, 552, and histoplasmosis, 554, and Kaposi s sarcoma, 552, and leishmaniasis, 555, 565 and leprosy, 553, and lupus erythematosus, , 565 and molluscum contagiosum, 553, 559 and mycobacterial infections, 553, and sarcoidosis, 555, 564 and tuberculosis, 553, 561 and warts, 553 clinical features of, 550 definition of, 549 diagnosis of, 551 historical aspects of, immunopathogenesis of, in children, incidence of, 550 management of, 551 risk factors for, 551 Immunoglobulin E, in pruritic papular eruption, 452 Immunomodulatory drugs, with antiretroviral therapy, 542 India, HIV/AIDS epidemiology in, 414
5 INDEX 575 Infections, cutaneous, with HIV/AIDS. See Cutaneous infections. Inflammatory noninfectious dermatoses, with HIV/AIDS, atopic dermatitis, 442 chronic actinic dermatitis, 446 eosinophilic folliculitis, clinical features of, differential diagnosis of, 430, 453 syndrome and, 554, management of, pathogenesis of, 439 pathology of, 439 photosensitivity, pruritus, psoriasis, Reiter s syndrome, seborrheic dermatitis, xerosis, 442 Insulin resistance, antiretroviral therapy and, 543 Interferons, in pruritic papular eruption, 452 Interleukins, in pruritic papular eruption, 452 Isotretinoin, for eosinophilic folliculitis, 440 Itraconazole for eosinophilic folliculitis, 440 to prevent histoplasmosis, in HIV/AIDS, J Jarisch-Herxheimer reaction, to syphilis treatment, 503 K Kaposi s sarcoma, anogenital lesions in, 513 antiretroviral agents and, 510, 515, 516 classification of, 509 clinical features of, cutaneous lesions in, diagnosis of, differential diagnosis of, 514 epidemiology of, 510 etiopathogenesis of, histology of, 514 human herpesvirus 8 and, , 552, syndrome and, 552, in children, 514 lymphadenopathic, 514 management of, chemotherapy in, 517 experimental therapies in, for localized mucocutaneous lesions, 517 in developing countries, 518 radiation therapy in, 517 retinoids in, 517 oral mucosal lesions in, 513 prognosis for, 515 pulmonary lesions in, staging of, 515 visceral lesions in, , 515 Kenya, HIV/AIDS epidemiology in, 425 L Lactic acidosis, antiretroviral therapy and, Latin America, HIV/AIDS epidemiology in, 416 Leishmaniasis syndrome and, 555, 565 with HIV/AIDS, Leprosy, syndrome and, 553, Lipid abnormalities, antiretroviral therapy and, 543 Lipodystrophy, antiretroviral therapy and, Lues maligna, with HIV infection, 499 Lupus erythematosus, immune reconstitution inflammatory syndrome and, , 565 Lymphadenopathy, with Kaposi s sarcoma, 514 Lymphedema, with Kaposi s sarcoma, Lymphoma, cutaneous, with HIV infection, M Major histocompatibility complex, and adverse drug reactions, 470 Malignant syphilis, with HIV infection, 499 Melanoma, with HIV infection, 524 Merkel cell carcinoma, with HIV infection, 525 Metabolic complications, of antiretroviral therapy, 542 Metformin, for lipodystrophy, 544
6 576 INDEX Methicillin-resistant Staphylococcus aureus infections, risk of, with HIV/AIDS, 474 Mexico, HIV/AIDS epidemiology in, 416 Middle East, HIV/AIDS epidemiology in, 417 Miliary tuberculosis, with HIV/AIDS, 485 Molluscum contagiosum syndrome and, 553, 559 with HIV/AIDS, Morbilliform exanthematous drug reactions, in HIV infection, Mucocutaneous leishmaniasis, with HIV/AIDS, 486 Mucocutaneous lesions in HIV/AIDS, in children, 533 in Kaposi s sarcoma, 517 Mucosal ulcers, in acute retroviral syndrome, 432 Mycobacterial infections syndrome and, 553, with HIV/AIDS, 485 N Neuralgia, postherpetic, with HIV/AIDS, 477 Neurologic complications, of acute retroviral syndrome, 432 Neurosyphilis, with HIV infection, 501, 502, 504 Nodular prurigo, versus pruritic papular eruption, 455 Nonnucleoside reverse transcriptase inhibitors, mechanism of action of, 540 Nontreponemal tests, for syphilis, North Africa, HIV/AIDS epidemiology in, 417 North America, HIV/AIDS epidemiology in, Nucleoside reverse transcriptase inhibitors, mechanism of action of, O Oceania, HIV/AIDS epidemiology in, 417 Ocular syphilis, with HIV infection, Oral mucosal lesions, in Kaposi s sarcoma, 513 Organ transplant recipients, skin cancer in. See Skin cancer. P p24 enzyme immunoassays, for acute retroviral syndrome, 434 Papua New Guinea, HIV/AIDS epidemiology in, 417 Papular urticaria, versus pruritic papular eruption, 455 Parasitic infections, with HIV/AIDS. See Cutaneous infections. Pegylated liposomal doxorubicin, for Kaposi s sarcoma, 516, 517 Penicillium marneffei infections, with HIV/AIDS, 483 Pentoxifylline, for pruritic papular eruption, 455 Phenotypic resistance assays, in drug resistance testing, Photosensitivity, with HIV/AIDS, Pityrosporal folliculitis, versus pruritic papular eruption, 455 Pneumocystis jiroveci infections, with HIV/AIDS, 483 Podophyllotoxin, for human papillomavirus, 479 Postherpetic neuralgia, with HIV/AIDS, 477 Procaine penicillin, for neurosyphilis, 504 Protease inhibitors, mechanism of action of, 540 Pruritic papular eruption, with HIV infection, arthropod hypersensitivity in, clinical features of, differential diagnosis of, etiology of, hematologic and immunologic findings in, immune dysregulation in, 450 management of, 455 pathology of, prevalence of, 450 Pruritus, with HIV/AIDS, Psoriasis, with HIV/AIDS, Pulmonary complications, of acute retroviral syndrome, 432
7 INDEX 577 Pulmonary lesions, in Kaposi s sarcoma, R Radiation therapy, for Kaposi s sarcoma, 517 Reiter s syndrome, with HIV/AIDS, Retinoids, for Kaposi s sarcoma, 517 Ritonavir, for HIV infection, 542 Rosiglitazone, for lipodystrophy, 544 Russian Federation, HIV/AIDS epidemiology in, S Sarcoidosis, syndrome and, 555, 564 Sarcoptes scabiei infections, with HIV/AIDS, Scabies, with HIV/AIDS, Seborrheic dermatitis, with HIV/AIDS, Skin biopsy, for acute retroviral syndrome, 434 Skin cancer, HIV infection and, cutaneous lymphoma, effect on natural history, 524 highly active antiretroviral therapy and, 525 in organ transplant recipients, highly active antiretroviral therapy and, 523 level of immunosuppression and, 522, 523 management of, 525 melanoma, 524 Merkel cell carcinoma, 525 nonmelanoma cancer, risk factors for, Southern Africa, HIV/AIDS epidemiology in, Squamous cell carcinoma. See Skin cancer. Staphylococcus aureus infections, with HIV/ AIDS, Stevens-Johnson syndrome, with HIV infection, , Sub-Saharan Africa, HIV/AIDS epidemiology in. See HIV/AIDS, global epidemiology of. Syphilis, with HIV infection, cardiovascular syphilis, , 504 clinical features of, 498 diagnosis of, epidemiology of, gummatous syphilis, 500, 504 latent syphilis, 500, malignant syphilis, 499 management of, neurosyphilis, 501, 502, 504 ocular syphilis, pathology of, primary syphilis, 498, secondary syphilis, , tertiary syphilis, , 504 Systemic lupus erythematosus, immune reconstitution inflammatory syndrome and, 555, 565 T Tanzania, HIV/AIDS epidemiology in, 425 T-cell activation, and adverse drug reactions, 470 T-cell counts, in pruritic papular eruption, 452 Toxic epidermal necrolysis, with HIV infection, , Treponemal tests, for syphilis, Trichophyton rubrum infections, with HIV/AIDS, 484 Trimethoprim-sulfamethoxazole, adverse reactions to, Tuberculosis syndrome and, 553, 561 with HIV/AIDS, 485 Tumid lupus, immune reconstitution inflammatory syndrome and, 555, 565 U Uganda, HIV/AIDS epidemiology in, 425 Ukraine, HIV/AIDS epidemiology in, 415 Ulcers Buruli, with HIV/AIDS, 485 genital, with HIV/AIDS, 475 mucosal, with acute retroviral syndrome, 432 UVB phototherapy, for pruritic papular eruption, 455
8 578 INDEX V Vaccines for human papillomavirus, for varicella zoster virus, 477 Varicella zoster virus, with HIV/AIDS, Viral infections, with HIV/AIDS. See Cutaneous infections. Virtual phenotypic resistance assays, in drug resistance testing, 545 Visceral leishmaniasis syndrome and, 563 with HIV/AIDS, Visceral lesions, in Kaposi s sarcoma, 513, 515 W Warts, syndrome and, 553 West Africa, HIV/AIDS epidemiology in, Western blot tests, for acute retroviral syndrome, 434 X Xerosis, with HIV/AIDS, 442 Z Zimbabwe, HIV/AIDS epidemiology in, 425
Second Joint Conference 0f the British HIV Association [BHIVA] and the British Association for Sexual Health and HIV [BASHH]
Second Joint Conference 0f the British HIV Association [BHIVA] and the British Association for Sexual Health and HIV [BASHH] 20-23 April 2010, Manchester Central Convention Complex SECOND JOINT CONFERENCE
More informationDidactic Series. HIV related Dermatologic Manifestations. Ankita Kadakia, MD UC San Diego, Owen Clinic April 26, 2018
Didactic Series HIV related Dermatologic Manifestations Ankita Kadakia, MD UC San Diego, Owen Clinic April 26, 2018 1 Learning Objectives 1) Recognize common dermatologic manifestations associated with
More informationDidactic Series. Dermatologic Manifestations Associated with HIV/AIDS. Ankita Kadakia, MD UCSD Owen Clinic 12/11/2014
Didactic Series Dermatologic Manifestations Associated with HIV/AIDS Ankita Kadakia, MD UCSD Owen Clinic 12/11/2014 ACCREDITATION STATEMENT: University of California, San Diego School of Medicine is accredited
More informationLahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease
Lahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease Faculty representative: Eva Piessens, MD, MPH Resident representative: Karen Ganz, MD Revision date: February 1, 2006
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adhesive tape impression 1 Diff Quik in EPD diagnosis, 583 Allergy(ies). See also Food allergy; specific types, e.g., Culicoides hypersensitivity
More informationMUCOCUTANEOUS MANIFESTATIONS OF HIV/AIDS IN ADOLESCENTS
MUCOCUTANEOUS MANIFESTATIONS OF HIV/AIDS IN ADOLESCENTS Dr. Y.S.MARFATIA Prof. and Head, Dept. Skin & V.D. Medical college, Vadodara LET US CREATE BRILLIANCE TOGETHER MEDICAL COLLEGE, VADODARA Editor in
More informationIndex. Nurs Clin N Am 41 (2006) Note: Page numbers of article titles are in boldface type.
Nurs Clin N Am 41 (2006) 481 486 Index Note: Page numbers of article titles are in boldface type. A Acquired immunodeficiency syndrome (AIDS), after age 55, 469 479 epidemiology, 469 471 risk factors in
More informationGOALS AND OBJECTIVES INFECTIOUS DISEASE
GOALS AND OBJECTIVES INFECTIOUS DISEASE Infectious Disease and HIV Overview: The Infectious Diseases Program at the University of Southern California prepares trainees for the management of problems in
More informationClinical Manifestations of HIV
HIV Symptoms Diane Havlir, MD Professor of Medicine and Chief, HIV/AIDS Division University of California, San Francisco (UCSF) WorldMedSchool; July 2, 2013 1 Clinical Manifestations of HIV! Result from
More informationHIV AND THE SKIN DR. FREDAH MALEKA DERMATOLOGY UNIVERSITY OF PRETORIA:KALAFONG
KEY FEATURES HIV AND THE SKIN DR. FREDAH MALEKA DERMATOLOGY UNIVERSITY OF PRETORIA:KALAFONG Atypical presentation of common disorders Severe or exaggerated presentations Sudden acute exacerbations Treatment
More informationCommon dermatological conditions in the HIV patient
South African Family Practice 2019; 61(1):21-26 Open Access article distributed under the terms of the Creative Commons License [CC BY-NC-ND 4.0] http://creativecommons.org/licenses/by-nc-nd/4.0 S Afr
More informationالعصوي الوعاي ي الورام = angiomatosis Bacillary
1 / 7 BACILLARY ANGIOMATOSIS Epidemiology BA is most commonly seen in patients with acquired immunodeficiency syndrome (AIDS) and a CD4 count less than 50 cells/mm 3, with an incidence of 1.2 cases per
More information5. Over the last ten years, the proportion of HIV-infected persons who are women has: a. Increased b. Decreased c. Remained about the same 1
Epidemiology 227 April 24, 2009 MID-TERM EXAMINATION Select the best answer for the multiple choice questions. There are 60 questions and 9 pages on the examination. Each question will count one point.
More informationIndex. derm.theclinics.com. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Abatacept for DLE, 493 for SLE, 497 Ablative therapies, localized, for cutaneous T-cell lymphoma, 502 506. See also Cutaneous T-cell lymphoma,
More informationHIV/AIDS in East Asia
HIV/AIDS in East Asia Yonsei University Graduate School of Global Health Sohn, Myong Sei Epidemiology Global summary of the AIDS epidemic, 2008 Number of people living with HIV in 2008 Total Adults Women
More informationAIDS at 25. Epidemiology and Clinical Management MID 37
AIDS at 25 Epidemiology and Clinical Management Blood HIV Transmission transfusion injection drug use Sexual Intercourse heterosexual male to male Perinatal intrapartum breast feeding Regional HIV and
More informationOriginal Research Article. Lalremruati Sailo 1, Th Bijayanti Devi 1, Th Bhimo Singh 2, Bishurul N. A. Hafi 1 *
International Journal of Research in Dermatology http://www.ijord.com Original Research Article DOI: http://dx.doi.org/10.18203/issn.2455-4529.intjresdermatol20175374 Dermatological manifestations of acquired
More informationChapter 11. Sexually Transmitted Diseases
Chapter 11. Sexually Transmitted Diseases General Guidelines Persons identified as having one sexually transmitted disease (STD) are at risk for others and should be screened as appropriate. Partners of
More informationReviewing Sexual Health and HIV NM2715
Reviewing Sexual Health and HIV NM2715 Learning objectives To observe and learn from a case study. What happens to a couple who attend a GUM clinic, for screening and subsequent treatment? Revision of
More informationUndergraduate Dermatology Curriculum July 2016
Undergraduate Dermatology Curriculum July 2016 British Association of Dermatologists Introduction This document is the 2016 revised dermatology undergraduate curriculum (UK) from the British Association
More informationmedical monitoring: clinical monitoring and laboratory tests
medical monitoring: clinical monitoring and laboratory tests Purpose of monitoring Check on the physical, psychological and emotional condition of the patient Detect other treatable conditions Identify
More informationAIDS at 30 Epidemiology and Clinical Epidemiology and Management MID 37
AIDS at 30 Epidemiology and Clinical Management Blood HIV Transmission transfusion injection drug use Sexual Intercourse heterosexual male to male Perinatal intrapartum breast feeding Adults and children
More informationDESCRIPTIONS FOR MED 3 ROTATIONS Dermatology A3S
Regardless of your future field of practice, you will be exposed to a considerable amount of dermatology and this rotation provides you the chance to see a range of skin diseases. You will have the opportunity
More informationCopyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN
UNAIDS DATA TABLES 2011 Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN 978-92-9173-945-5 UNAIDS / JC2225E The designations employed and the presentation of
More informationIndex. Angiosarcoma diagnosis, 47 lymphedema-related vs. non-lymphedemarelated, 48
A Acneiform rash biopsy, 134 cetuximab, EGFR, 132 133 diagnosis, 131 patient history, 131 134 treatment, 134 135 Acne vulgaris, 109 AGA. See Androgenetic alopecia Alopecia areata, 148 American Joint Committee
More informationImmunodeficiencies HIV/AIDS
Immunodeficiencies HIV/AIDS Immunodeficiencies Due to impaired function of one or more components of the immune or inflammatory responses. Problem may be with: B cells T cells phagocytes or complement
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adaptive immune response biologic response modifiers and, 735 737 S-Adenosylmethionine (SAMe) for hepatitis, 825 826 Albinterferon for hepatitis,
More informationbe the presenting symptom of HIV-related illness. 4 CD4 cell count and CD4 cell percentage are key markers for determining disease progress and the ri
Cutaneous Maniestations In HIV Positive Paediatric Patients Kondreddy B 1, Kuruvila M 2, Ullal KR 3, Bhat K 4 1 Resident, 2 Professor, 3 Senior Resident, Department of Dermatology, Venereology and Leprosy,
More informationOF HIV / AIDS EXPOSURE ACUTE HIV INFECTION (1-2W.) AIDS SEXUAL, BLOOD, VERTICAL Days to weeks(2-4w.) 5-8% *20-25%, 6y. *50%, 10y. *<5%, 2y.
Clinical Manifestations & Management of HIV Dr.Shervin Shokouhi Infectious Disease Specialist & Associate Professor of Shaheed Beheshti University of Medical Sciences 1 CLINICAL MANIFESTATIONS OF HIV /
More informationMucocutaneous Manifestations In Hiv Patients In A Tertiary Care Centre
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 7 Ver. V (July. 2017), PP 58-64 www.iosrjournals.org Mucocutaneous Manifestations In Hiv Patients
More informationMain global and regional trends
I N T R O D U C T I O N Main global and regional trends Promising developments have been seen in recent years in global efforts to address the AS epidemic, including increased access to effective treatment
More informationCan we treat our way out of the HIV epidemic?
Can we treat our way out of the HIV epidemic? Richard E. Chaisson, MD Center for AIDS Research Center for TB Research Johns Hopkins University Schoolboy s (and politician s) tricks for evading the question
More informationTHE BENCHMARK. UNAIDS and the polling company Zogby International surveyed the world on what people think about the AIDS epidemic and response.
THE BENCHMARK UNAIDS and the polling company Zogby International surveyed the world on what people think about the AIDS epidemic and response. THE BENCHMARK UNAIDS and the polling company Zogby International
More informationThe Old, The New and the Reemerging-HIV Dermatology. Toby Maurer, MD
The Old, The New and the Reemerging-HIV Dermatology Toby Maurer, MD 1 Psoriasis Widespread psoriasis, especially if it was once stable, predicts falling CD4 count?resistance to ART??Non-adherence? Tx:
More information0BCore Safety Profile. Pharmaceutical form(s)/strength: Cream 1% DK/H/PSUR/0009/005 Date of FAR:
0BCore Safety Profile Active substance: Pimecrolimus Pharmaceutical form(s)/strength: Cream 1% P-RMS: DK/H/PSUR/0009/005 Date of FAR: 06.06.2013 4.3 Contraindications Hypersensitivity to pimecrolimus,
More informationOral Manifestations of HIV: Case Studies
NORTHWEST AIDS EDUCATION AND TRAINING CENTER Oral Manifestations of HIV: Case Studies David Spach, MD Principal Investigator and Clinical Director, Northwest AETC Professor of Medicine, Division of Infectious
More informationMeasure #161: HIV/AIDS: Adolescent and Adult Patients with HIV/AIDS Who Are Prescribed Potent Antiretroviral Therapy
Measure #161: HIV/AIDS: Adolescent and Adult Patients with HIV/AIDS Who Are Prescribed Potent Antiretroviral Therapy 2012 PHYSICIAN QUALITY REPTING OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION:
More informationOriginal Article. Abstract. Introduction
Original Article The prevalence of skin diseases among the geriatric patients in Eastern Turkey Serap Gunes Bilgili, 1 Ayse Serap Karadag, 2 Hatice Uce Ozkol, 3 Omer Calka, 4 Necmettin Akdeniz 5 Department
More informationCUTANEOUS MANIFESTATIONS IN HIV POSITIVE PATIENTS
CUTANEOUS MANIFESTATIONS IN HIV POSITIVE PATIENTS CUTANEOUS MANIFESTATIONS IN HIV POSITIVE PATIENTS Wichai Supanaranond 1, Varunee Desakorn 1, Chasuree Sitakalin 2, Nyunt Naing 3 and Pornchai Chirachankul
More informationWhy is there not enough coordination and collaboration between programmes to implement collaboration TB/HIV activities
Why is there not enough coordination and collaboration between programmes to implement collaboration TB/HIV activities Olga P. Frolova Head of the TB/HIV Health Care Centre, Ministry of Health Social Development,
More informationPotential etiologies of infection in these patients are diverse, including common and uncommon opportunistic infections.
In the name of God Principles of post Tx infections 1: Potential etiologies of infection in these patients are diverse, including common and uncommon opportunistic infections. Infection processes can progress
More informationCONDITIONS OF THE SKIN
CONDITIONS OF THE SKIN UCSF/SFGH Family & Community Medicine Residency Program Educational Objectives I. Knowledge The resident will be able to discuss the definition, diagnosis, and initial management
More informationHuman Immunodeficiency Virus
Human Immunodeficiency Virus Isolated in 1983 by Luc Montagnier & Robert Gallo, separately. Genetic material is RNA Carries reverse transcriptase, an enzyme that makes DNA out of RNA in the host cell Cells
More informationNewly diagnosed HIV patient. Dr. Heila Redpath 06 FEBRUARY 2014
Newly diagnosed HIV patient Dr. Heila Redpath 06 FEBRUARY 2014 PRIMARY HIV INFECTION: SEROCONVERSION SYMPTOMATIC HIV INFECTION AND AIDS ASYMPTOMATIC LATENT INFECTION CLOSED CIRCLES: CD4 cells OPEN
More informationb) SKILLS The student should be able to
1. GOAL The aim of teaching the undergraduate student in Dermatology, S.T.D. and Leprology is to impart such knowledge and skills that may enable him to diagnose and treat common ailments and to refer
More informationProkaryotic Biology. VIRAL STDs, HIV-1 AND AIDS
Prokaryotic Biology VIRAL STDs, HIV-1 AND AIDS Prokaryotic Biology FROM THE CDC VIRAL STDs, HIV-1 AND AIDS VIRAL STDs & CONTACT VIRAL DISEASES A. GENITAL HERPES & COLD SORES 1. HERPES SIMPLEX VIRUS-2 (HHV-2)
More informationScaling up priority HIV/AIDS interventions in the health sector
TOWARDS UNIVERSAL ACCESS? Scaling up priority HIV/AIDS interventions in the health sector Yves Souteyrand, WHO October 2011 Towards universal access targets UN General Assembly High level Meeting June
More informationpage: 582 alphabetical Index by Causes picture cause basic lesion search contents print last screen viewed back next
page: 582 Index by Causes basic lesion cause picture alphabetical Index by Causes page: 583 Mechanical factors Acquired digital fibrokeratoma,393 Angioma,418 Atopic dermatitis in the adult: xerosis, lichenification
More informationSubject Index. Dry desquamation, see Skin reactions, radiotherapy
Subject Index Actinic keratosis disseminated disease 42 surgical excision 42 AIDS, see Kaposi s sarcoma Amifostine, skin reaction prophylaxis 111 Basal cell carcinoma, superficial X-ray therapy Bowen s
More informationTrends in HIV/AIDS epidemic in Asia, and its challenge. Taro Yamamoto Institute of Tropical Medicine Nagasaki University
Trends in HIV/AIDS epidemic in Asia, and its challenge Taro Yamamoto Institute of Tropical Medicine Nagasaki University Millennium Development Goals Goal 1. Eradicate extreme poverty and hunger Goal 2.
More informationhttp://www.savinglivesuk.com/ HIV Awareness Study Morning 24 th November 2017 Agenda HIV Basics & Stages of HIV HIV Testing, Health Advising & Sexual Health Saving Lives Antiretroviral Medication Antenatal/Postnatal
More informationInt. J. Curr. Microbiol. App. Sci (2015) 4(7):
ISSN: 2319-7706 Volume 4 Number 7 (2015) pp. 498-510 http://www. ijcmas. com Original Research Article Correlation between Cutaneous Manifestations and Degree of Immunosuppression (CD-4 Count) in Sero-Positive
More informationModule 1: HIV epidemiology, transmission and prevention
Session 1 Module goals Module 1 Participants will be able to: -offer an insight into the epidemiological situation in the country and worldwide -present the HIV transmission modes and the broad approaches
More information10/17/2015. Chapter 55. Care of the Patient with HIV/AIDS. History of HIV. HIV Modes of Transmission
Chapter 55 Care of the Patient with HIV/AIDS All items and derived items 2015, 2011, 2006 by Mosby, Inc., an imprint of Elsevier Inc. All rights reserved. History of HIV Remains somewhat obscure The earlier
More informationClinical profile of skin diseases in accident and emergency department attenders
Hong Kong J. Dermatol. Venereol. (2007) 15, 4-9 Original Article Clinical profile of skin diseases in accident and emergency department attenders CY Chan, KL Kam, CA Graham, TH Rainer, NM Luk Skin problems
More informationHuman Immunodeficiency Virus. Acquired Immune Deficiency Syndrome AIDS
Human Immunodeficiency Virus Acquired Immune Deficiency Syndrome AIDS Sudden outbreak in USA of opportunistic infections and cancers in young men in 1981 Pneumocystis carinii pneumonia (PCP), Kaposi s
More informationContents. 3 Diagnostic Tests and Studies Introduction Examination... 27
Contents 1 Normal Anatomy... 1 1.1 Introduction... 1 1.2 Surface Landmarks... 1 1.3 Oral Mucosa... 3 1.4 Tongue... 5 1.5 Floor of Mouth... 6 1.6 Palate... 6 1.7 Dentition... 7 1.8 Temporomandibular Joint...
More informationHIV IN OKLAHOMA MAKING A DIFFERENCE
HIV IN OKLAHOMA MAKING A DIFFERENCE Madhuri Lad, DO, FACOI, AAHIVS Assistant Program and Medical Director OSU Internal Medicine Specialty Services HIV Program Clinical Assistant Professor Rashes Demographics
More informationMID-TERM EXAMINATION
Epidemiology 227 May 2, 2007 MID-TERM EXAMINATION Select the best answer for the multiple choice questions. There are 75 questions and 11 pages on the examination. Each question will count one point. Notify
More informationProgram to control HIV/AIDS
90-90-90 Program to control HIV/AIDS Hamid Sharifi Associate Professor in Epidemiology [sharifihami@gmail.com] 1 Targets for ending the AIDS epidemic 2 New HIV infections in low- and middle-income countries,
More informationSyphilis Treatment Protocol
STD, HIV, AND TB SECTION Syphilis Treatment Protocol CLINICAL GUIDANCE FOR PRIMARY AND SECONDARY SYPHILIS AND LATENT SYPHILIS www.lekarzol.com (4/2016) Page 1 of 8 Table of Contents Description... 3 Stages
More informationHIV in Obstetrics and Gynecology
FAST FACTS HIV in Obstetrics and Gynecology Indispensable Guides to Clinical by J Richard Smith, Naomi Low-Beer and Bruce A Barron Practice HIV infection 7 Managing infected women 13 Preconceptual care
More informationOI prophylaxis When to start, when to stop. Eva Raphael, MD MPH Family and community medicine, pgy-2 University of California, San Francisco
OI prophylaxis When to start, when to stop Eva Raphael, MD MPH Family and community medicine, pgy-2 University of California, San Francisco Learning Objectives o Recognize when to start OI prophylaxis
More information9/9/17. Disclosures" Dermatology in Primary Care: Recognition and treatment of common disorders of the skin" A preview" Classic skin infections"
Disclosures Dermatology in Primary Care: Recognition and treatment of common disorders of the skin I have no conflicts of interest to disclose. I may discuss off-label use of treatments for cutaneous disease.
More informationUpdates in HIV Medicine. Dr. Jacky Chan Associate Consultant Princess Margaret Hospital
Updates in HIV Medicine Dr. Jacky Chan Associate Consultant Princess Margaret Hospital What is HIV? HIV - Human immunodeficiency virus Retrovirus Human Immunodeficiency virus type-1 (HIV-1) Global AIDS
More informationHerpes Simplex Viruses: Disease Burden. Richard Whitley The University of Alabama at Birmingham Herpes Virus Infection and Immunity June 18-20, 2012
Herpes Simplex Viruses: Disease Burden Richard Whitley The University of Alabama at Birmingham Herpes Virus Infection and Immunity June 18-20, 2012 Mucocutaneous HSV Infections Life-Threatening HSV Diseases
More informationFACULTY DISCLOSURE PRACTICE CHANGE
FACULTY DISCLOSURE I have the following financial relationships with the manufacturer(s) of any commercial product(s) and/or provider of commercial services discussed in this CME activity. Spouse owns
More informationHUMAN IMMUNODEFICIENCY VIRUS (HIV) TESTING (Diagnosis)
HUMAN IMMUNODEFICIENCY VIRUS (HIV) TESTING (Diagnosis) NCD Source: Program Memorandum AB-02-110, Effective 11-25-02; Medicare NCD Manual, July 2003 Release; October 2003 Release; October 2004 Release;
More informationHIV- INFECTION WHO case definition for HIV infection 2007 Adults and children 18 months or older HIV infection is diagnosed based on:
HIV- INFECTION Human immunodeficiency virus (HIV) is a blood-borne, sexually transmissible virus (see the image below.) The virus is typically transmitted via sexual intercourse, shared intravenous drug
More informationOntario s Referral and Listing Criteria for Adult Pancreas-After- Kidney Transplantation
Ontario s Referral and Listing Criteria for Adult Pancreas-After- Kidney Transplantation Version 2.0 Trillium Gift of Life Network Adult Pancreas-After-Kidney Transplantation Referral & Listing Criteria
More informationGROUP 15 TOPICAL PREPARATIONS
- 105 - GROUP 15 15.1 DERMATOLOGICAL PREPARATIONS 15.1.1 TOPICAL ANTIFUNGALS CLOTRIMAZOLE Indication: Treatment of susceptible fungal infections, dermatophytoses, superficial mycoses, and cutaneous candidiasis
More informationHow has the Polio Eradication Initiative influenced the global AIDS response? Bradley S. Hersh, MD, MPH
How has the Polio Eradication Initiative influenced the global AIDS response? Bradley S. Hersh, MD, MPH Presentation Outline Big history of global HIV epidemic Current status of HIV and the global AIDS
More informationAPPENDIX A LIST OF JOURNALS PUBLISHED IN AFRICA AND COVERED IN THE MEDLINE, SCI AND SSCI DATABASES
APPENDIX A LIST OF JOURNALS PUBLISHED IN AFRICA AND COVERED IN THE MEDLINE, SCI AND SSCI DATABASES MEDLINE Algeria: Archives. Institut Pasteur d Algerie Egypt: Eastern Mediterranean Health Journal The
More informationINTEGRATING HIV INTO PRIMARY CARE
INTEGRATING HIV INTO PRIMARY CARE ADELERO ADEBAJO, MD, MPH, AAHIVS, FACP NO DISCLOSURE 1.2 million people in the United States are living with HIV infection and 1 in 5 are unaware of their infection.
More informationUNAIDS 2013 AIDS by the numbers
UNAIDS 2013 AIDS by the numbers 33 % decrease in new HIV infections since 2001 29 % decrease in AIDS-related deaths (adults and children) since 2005 52 % decrease in new HIV infections in children since
More informationGLOBAL MARKETS FOR TREATMENT AND DIAGNOSIS OF SEXUALLY TRANSMITTED DISEASES
GLOBAL MARKETS FOR TREATMENT AND DIAGNOSIS OF SEXUALLY TRANSMITTED DISEASES PHM005C January 2013 Peggy Lehr Project Analyst ISBN: 0-89336-646-3 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481
More informationWHAT DO U KNOW ABOUT STIS?
WHAT DO U KNOW ABOUT STIS? Rattiya Techakajornkeart MD. Bangrak STIs Cluster, Bureau of AIDS, TB and STIs, Department of Disease Control, MOPH, Thailand SEXUALLY TRANSMITTED INFECTIONS? STIs Infections
More informationGLOBAL STATISTICS FACT SHEET 2015
FACT SHEET 2015 GLOBAL STATISTICS 15.8 people accessing antiretroviral therapy (June 2015) 36.9 [34.3 41.4 ] people globally were living with HIV (end 2014) 2 [1.9 2.2 ] people became newly infected with
More informationGeographic Opportunistic Infections
Epidemiology of HIV Associated Opportunistic Infections in the United States Siriluck Anunnatsiri, MD Division of Infectious Diseases and Tropical Medicine Department of Medicine, Khon Kaen University
More informationTB Intensive Tyler, Texas December 2-4, Tuberculosis and HIV Co-Infection. Lisa Y. Armitige, MD, PhD. December 4, 2008.
TB Intensive Tyler, Texas December 2-4, 2008 Tuberculosis and HIV Co-Infection Lisa Y. Armitige, MD, Ph.D. December 4, 2008 Tuberculosis and HIV Co Infection Lisa Y. Armitige, MD, PhD Assistant Professor
More informationTB/HIV Co-Infection. Tuberculosis and HIV
TB Intensive Tyler, Texas June 2-4, 2010 TB/HIV Co-Infection Lisa Y Armitige, MD, PhD June 3, 2010 Tuberculosis and HIV Co-Infection Lisa Y Armitige, MD, PhD Medical Consultant Heartland National TB Center
More information2. Clinical Manifestations (Pediatric HIV Infection)
Page 1 of 6 HOUSTON ROMANIA SOUTHERN AFRICA MEXICO HOME CONTACT Friday, July 25, 2003 Pediatric HIV Infection by Mark W. Kline, M.D. 1. Introduction 2. Clinical Manifestations 3. Diagnosis 2. Clinical
More information227 28, 2010 MIDTERM EXAMINATION KEY
Epidemiology 227 April 28, 2010 MIDTERM EXAMINATION KEY Select the best answer for the multiple choice questions. There are 64 questions and 9 pages on the examination. Each question will count one point.
More informationAntiviral Drugs Lecture 5
Antiviral Drugs Lecture 5 Antimicrobial Chemotherapy (MLAB 366) 1 Dr. Mohamed A. El-Sakhawy 2 Introduction Viruses are microscopic organisms that can infect all living cells. They are parasitic and multiply
More informationCutaneous Manifestations
National HIV Curriculum PDF created July 8, 2018, 9:18 am Cutaneous Manifestations This is a PDF version of the following document: Section 1: Basic HIV Primary Care Topic 3: Cutaneous Manifestations You
More informationIndex. derm.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A AAD. See American Academy of Dermatology. Abscesses Acetaminophen and dengue fever, 36 Acquired immunodeficiency syndrome. See Human immunodeficiency
More informationDermatologist Venereologist MD, PhD
Vassiliki Mousatou Dermatologist Venereologist MD, PhD Genital warts Genital herpes Syphilis Gonococcal and no gonococcal urethritis HIV Hepatitis B and C Also: Lymphogranuloma venereum and Granuloma
More informationMucocutaneous manifestations among persons receiving highly active anti-retroviral therapy
International Journal of Research in Dermatology http://www.ijord.com Original Research Article DOI: http://dx.doi.org/10.18203/issn.2455-4529.intjresdermatol20170800 Mucocutaneous manifestations among
More informationImproving accessibility to antiretroviral drugs: A south-south collaboration
Improving accessibility to antiretroviral drugs: A south-south collaboration Jaideep A Gogtay MD Cipla Ltd Mumbai jgogtay@cipla.com Adults and children estimated to be living with HIV at the end of 2000
More informationTuberculosis-related deaths in people living with HIV have fallen by 36% since 2004.
F A C T S H E E T 2014 GLOBAL STATISTICS People living with HIV In 2013, there were 35 [33.2 37.2 ] people living with HIV. - Since the start of the epidemic, around 78 [71 87 ] people have become infected
More informationUndergraduate. Introduction:
Undergraduate The main base of the chair is surgical units 2 clinics Regional SVD and Republics SVD. The clinical bases of the department completely fit the profile of training, are part of the dermatovenerologis
More informationIn 2013, around 12.9 million people living with HIV had access to antiretroviral therapy.
F A C T S H E E T 2014 GLOBAL STATISTICS People living with HIV In 2013, there were 35 [33.2 37.2 ] people living with HIV. - Since the start of the epidemic, around 78 [71 87 ] people have become infected
More informationOntario s Referral and Listing Criteria for Adult Kidney Transplantation
Ontario s Referral and Listing Criteria for Adult Kidney Transplantation Version 3.0 Trillium Gift of Life Network Adult Kidney Transplantation Referral & Listing Criteria PATIENT REFERRAL CRITERIA: The
More informationRashes Not To Be Missed In Children
May 2016 Rashes Not To Be Missed In Children Dr Chan Yuin Chew Dermatologist Dermatology Associates Gleneagles Medical Centre Scope of presentation Focus on rashes May lead to significant morbidity if
More informationStudy of cutaneous manifestations in HIV infection
Original Research Article Study of cutaneous manifestations in HIV infection Kumari Neeti 1, Krishan Kewal 2*, Bhat Bela 2, Gupta Gunjan 2, Bist J S 3, Mehta Anil Kumar 3 1 Assistant Professor, 2 Senior
More informationAtopic Dermatitis and Primary Immunodeficiency: When Should I Worry?
Atopic Dermatitis and Primary Immunodeficiency: When Should I Worry? Markus Boos, MD PhD Attending Physician, Dermatology Seattle Children s Hospital Assistant Professor of Pediatrics, University of Washington
More informationImmunodeficiency. (2 of 2)
Immunodeficiency (2 of 2) Acquired (secondary) immunodeficiencies More common Many causes such as therapy, cancer, sarcoidosis, malnutrition, infection & renal disease The most common of which is therapy-related
More informationCOURSE DESCRIPTION AND STUDY REGULATIONS
COURSE DESCRIPTION AND STUDY REGULATIONS Course: SKIN AND VENEREAL DISEASES Course type: COMPULSORY ELECTIVE ECTS credits: 6 Nominated teacher(s): prof. dr. Tomaž Lunder, izr. prof. dr. Mateja Dolenc-Voljč
More informationWhy the basics? Back to Basics HIV Dermatology Immune reconstitution Acne. The HIV infected pt who starts ARV s 12/12/2012
Why the basics? Back to Basics HIV Dermatology 2012 Toby Maurer, MD University of California, San Francisco 1) The depleted low CD4 counts 2) The repleted aging pts 3) The group who starts ARV s at high
More informationAssessment of the patient with chronic HIV disease
Assessment of the patient with chronic HIV disease Author Ooi, Catriona, Rogers, Gary, Couldwell, Deborah Published 2014 Book Title HIV, Viral Hepatitis and STIs: A Guide for Primary Care Copyright Statement
More information